Cell Sciences has been serving the life science community as a supplier of quality immunochemicals and hematology reagents since 2000. Cell Sciences product categories include: cytokines and growth factors, chemokines, ELISA kits, ELISPOT kits, enzymes, hormones, kinases & phosphotases, cell lysates, monoclonal antibodies, polyclonal antibodies, proteins & peptides, small molecule antibodies, small molecule antigens and other associated reagents.Our specific native or recombinant proteins and antibodies (untagged, tagged, or labeled) include adhesion molecules, antimicrobial and host defense peptides, ECM molecules and CD antigens, chemokines, cytokines, enzymes, growth factors, hormones, interferons, interleukins, kinases and phosphatases, lymphokines, neurotrophic factors, receptors, regulatory peptide factors, signal transduction mediators, and toxins. Biomedical research and applications for our products include bioassays, immunoassays and -detection, flow cytometry in numerous biomedical interdisciplinary research areas focusing on angiogenesis and vascular research, apoptosis, cancer cell studies, cell growth and differentiation, coagulation studies, endocrinology, hematology, immunology, innate immunity, immunotherapy, inflammation, neurobiology, neuroimmunology, stem cell research, tissue engineering and wound healing.

Point 37 defines and drives strategic solutions to provide direction for new growth phase for technology based companies.

Overall business leader for $75M ASTRON / R*evolution product lines

Lead new product introduction group; direct product responsibility > $75M.

Managed the difficult shutdown of the Flat Panel Implanter business

Developed the High Energy (HE) market from 4% to almost 29% of the total available market (TAM) – in 1999, the HE TAM was $187M.